Congenital dyserythropoietic anemia type I with bone abnormalities, mutations of the CDAN I gene, and significant responsiveness to alpha-interferon therapy

Annals of Hematology

Volumn 85, Issue 9, 2006, Pages 591-595

  Goede, Jeroen S ^a   Benz, Rudolf ^b   Fehr, Joerg ^b   Schwarz, Klaus ^c   Heimpel, Hermann ^c  

^a TRIEMLI HOSPITAL   (Switzerland)

^b UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^c UNIVERSITY HOSPITAL ULM   (Germany)

Author keywords

CDA I; Dysostosis; Interferon; Skeleton

Indexed keywords

ALPHA2B INTERFERON; CODANIN 1; CYTOPLASM PROTEIN; DEFERIPRONE; DEFEROXAMINE; HEMOGLOBIN; IRON; PEGINTERFERON ALPHA2B; UNCLASSIFIED DRUG;

ADULT; ANEMIA; ARTICLE; AUTOSOMAL RECESSIVE DISORDER; BLOOD TRANSFUSION; BONE DEVELOPMENT; BONE MALFORMATION; CASE REPORT; CONGENITAL DYSERYTHROPOIETIC ANEMIA TYPE 1; DISEASE ASSOCIATION; DYSOSTOSIS; ERYTHROBLAST; ERYTHROPOIESIS; FEMALE; FRAMESHIFT MUTATION; GENE MUTATION; GENETIC ANALYSIS; HUMAN; IRON OVERLOAD; MALE; MEAN CORPUSCULAR VOLUME; NEUTROPENIA; ORTHOPEDIC SURGERY; PATHOGENESIS; PRIORITY JOURNAL; QUALITY OF LIFE; SPLENECTOMY; SWITZERLAND; SYNDACTYLY; TREATMENT OUTCOME; TREATMENT RESPONSE;

ADULT; ALLELES; ANEMIA, DYSERYTHROPOIETIC, CONGENITAL; BIOLOGICAL RESPONSE MODIFIERS; ERYTHROBLASTS; ERYTHROPOIESIS; FEMALE; FOOT DEFORMITIES, CONGENITAL; GLYCOPROTEINS; HUMANS; IMMUNOLOGIC FACTORS; INTERFERON-ALPHA; IRON OVERLOAD; MALE; MIDDLE AGED;

EID: 33747813566     PISSN: 09395555     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00277-006-0143-z     Document Type: Article

References (19)

1. Delaunay J, Iolascon A (1999) The congenital dyserythropoietic anemias. Bailliere's Best Pract Res Clin Haematol 12(4):691-705
2. Heimpel H (2004) Congenital dyserythropoietic anemias: Epidemiology, clinical significance and progress in understanding their pathogenesis. Ann Hematol 83(9):613-621
3. Heimpel H, Schwarz K, Ebnöther M, Goede JS, Heydrich D, Kamp T, Lothar P, Rath B, Roessler J, Schildknecht O, Schmid M, Wuillemin W, Einsiedler B, Leichtle R, Tamary H, Kohne E (2006) Congenital dyserythropoietic anemia type I (CDA I): Molecular genetics, clinical appearance and prognosis based on long-term observation. Blood 107(1):334-340
4. Wickramasinghe SN, Wood WG (2005) Advances in the understanding of the congenital dyserythropoietic anemias. Br J Haematol 131(4):431-446
5. Dgany O, Avidan N, Delaunay J, Krasnov T, Shalmon L, Shalev H, Eidelitz-Markus T, Kapelushnik J, Cattan D, Pariente A, Tulliez M, Cretien A, Schischmanoff PO, Iolascon A, Fibach E, Koren A, Rossler J, Le Merrer M, Yaniv I, Zaizov R, Ben-Asher E, Olender T, Lancet D, Beckmann JS, Tamary H (2002) Congenital dyserythropoietic anemia type I is caused by mutations in codanin-1. Am J Hum Genet 71(6):1467-1474
6. Tamary H, Dgany O, Proust A, Krasnov T, Avidan N, Eidelitz-Markus T, Tchernia G, Genevieve D, Cormier-Daire V, Bader-Meunier B, Ferrer-Vacher C, Munzer M, Gruppo R, Fibach E, Konen O, Yanif I, Delaunay J (2005) Clinical and molecular variability in congenital dyserythropoietic anemia type I. Br J Haematol 130(4):628-634
7. Tamary H, Shalmon L, Shalev H, Shaft D, Zoldan M, Resnitzky P, Korostishevky M, Zaizov R (1996) Localisation of the gene for congenital dyserythropoietic anemia type I to chromosome 15q15.1.3. Blood 88(Suppl 1):144
8. Shalev H, Kapelushnik J, Moser A, Dgany O, Krasnov T, Tamary H (2004) A comprehensive study of the neonatal manifestations of congenital dyserythropoietic anemia type I. J Pediatr Hematol Oncol 26(11):746-748
9. Holmberg L, Jansson L, Rausing A, Henriksson P (1978) Type I congenital dyserythropoietic anemia with myelopoietic abnormalities and hand malformations. Scand J Haematol 21:72-79
10. Brichard B, Vermylen C, Scheiff JM, Michaux JL, Ninane J, Cornu G (1994) Two cases of congenital dyserythropoietic anemia type I associated with unusual skeletal abnormalities of the limbs. Br J Haematol 86:201-202
11. Le Merrer M, Girot R, Parent P, Cormier Daire V, Maroteaux P (1995) Acral dysostosis dyserythropoiesis syndrome. Eur J Pediatr 154:384-388
12. Sabry MA, Zaki M, al Awadi SA, al Saleh Q, Mattar MS (1997) Non-haematological traits associated with congenital dyserythropoietic anemia type 1: A new entity emerging. Clin Dysmorph 6(3):205-212
13. Wickramasinghe SN (1998) Congenital dyserythropoietic anemias: Clinical features, haematological morphology and new biochemical data. Blood Rev 12:178-200
14. Roda L, Pasche J, Fournier A, Terorotua V, Wickramasinghe SN, Tamary H, Schischmanoff PO, Tchernia G, Delaunay J (2002) Congenital dyserythropoietic anemia, type 1, in a Polynesian patient: Response to interferon alpha2b. J Pediatr Hematol Oncol 24(6):503-506
15. Delaunay J (2003) Red cell membrane and erythropoiesis genetic defects. Hematol J 4(4):225-232
16. Tamary H, Dgany O, Proust A, Krasnov T, Avidan N, Tschernia G, Genevieve D, Comier-Darre V, Le Merrer M, Bader-Meunier B, Ferrero-Vacher C, Yaniv, I, Delaunay J (2004) Molecular basis of congenital dyserythropoietic anemia type I in French patients. Blood 104(11):13b
17. Pielage J, Stork T, Bunse I, Klambt C (2003) The Drosophila cell survival gene discs lost encodes a cytoplasmic codanin-1-like protein, not a homolog of tight junction PDZ protein Patj. Dev Cell 5(6):841-851
18. Marwaha RK, Bansal D, Trehan A, Garewal G (2005) Interferon therapy in congenital dyserythropoietic anemia type I/II. Pediatr Hematol Oncol 22(2):133-138
19. Lavabre-Bertrand T, Ramos J, Delfour C, Henry L, Guiraud I, Carillo S, Wagner A, Bureau JP, Blanc P (2004) Long-term alpha interferon treatment is effective on anemia and significantly reduces iron overload in congenital dyserythropoiesis type I. Eur J Haematol 73(5):380-383